Resmed Inc. buy UBS Group AG
Start price
22.05.23
/
50%
€210.60
Target price
22.05.24
-
Performance (%)
-3.75%
End price
23.05.24
€202.70
Summary
This prediction ended on 23.05.24 with a price of €202.70. With a performance of -3.75%, the BUY prediction by UBS_Group_AG finished with a loss. Dividends of €1.78 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Resmed Inc. | -0.514% | -0.514% | 51.386% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten